4//SEC Filing
Sandberg Eric 4
Accession 0000805928-22-000033
CIK 0000805928other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:10 PM ET
Size
14.3 KB
Accession
0000805928-22-000033
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Sandberg Eric
Chief Commercial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-03-16−6,000→ 6,000 total→ Common Stock (6,000 underlying) - Award
Employee Stock Option (right to purchase)
2022-03-16+60,576→ 60,576 totalExercise: $10.25Exp: 2032-03-16→ Common Stock (60,576 underlying) - Exercise/Conversion
Common Stock
2022-03-16+6,000→ 14,310 total - Award
Restricted Stock Units
2022-03-16+62,910→ 62,910 total→ Common Stock (62,910 underlying) - Tax Payment
Common Stock
2022-03-16$7.97/sh−1,512$12,051→ 12,798 total
Footnotes (7)
- [F1]This reflects the number of restricted stock units that became vested as of March 16, 2022.
- [F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F4]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
- [F5]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
- [F6]The exercise price of $10.25 represents a 25% premium over the fair market value of Axogen common stock on the date of the grant.
- [F7]All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2026 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on March 16, 2023 and on each anniversary thereafter.
Documents
Issuer
Axogen, Inc.
CIK 0000805928
Entity typeother
Related Parties
1- filerCIK 0001764446
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:10 PM ET
- Size
- 14.3 KB